Published on 1/3/2006 in the Prospect News Biotech Daily and Prospect News Convertibles Daily.
New Issue: Lehman prices $10.72 million notes linked to Amgen at 0.25%, up 10.75%
By Jennifer Chiou
New York, Jan. 3 - Lehman Brothers Holdings Inc. priced $10.72 million 0.25% notes performance linked to Amgen Inc. stock with a 10.75% initial exchange premium, according to a 424B5 filing with the Securities and Exchange Commission.
The notes can be exchanged for Amgen stock at a price of $87.6254 per share and automatically exchange at maturity or redemption if the stock is more valuable than par in cash.
Issuer: | Lehman Brothers Holdings Inc.
|
Issue: | Performance-linked medium-term senior series H notes
|
Underlying stock: | Amgen Inc.
|
Amount: | $10.72 million
|
Greenshoe: | $1.608 million
|
Maturity: | Jan. 6, 2012
|
Coupon: | 0.25%
|
Price: | Par
|
Exchange premium: | 10.75% (over $79.12 that Lehman paid to hedge the notes)
|
Exchange price: | $87.6254 (automatic exchange at maturity if more valuable)
|
Call: | Dec. 29, 2008 (automatic exchange if more valuable)
|
Pricing date: | Dec. 29
|
Settlement date: | Jan. 6
|
Underwriter: | Lehman Brothers
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.